SGMT Stock Analysis: Buy, Sell, or Hold?
SGMT - Sagimet Biosciences Inc. Series A Common Stock
$7.61
-0.42 (-5.23%)
▼
5d:
+29.86%
30d:
+45.23%
90d:
+34.22%
HOLD
MODERATE Confidence
Analysis Updated: May 1, 2026 12:00 AM ET
Earnings: May 14, 2026
10d
Get Alerted When SGMT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: SGMT is 7.0% above its trading range ($7.11). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: SGMT is 7.0% above its trading range ($7.11). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: SGMT is currently trading at $7.61, which is considered extended relative to its 30-day fair value range of $4.77 to $7.11.
Technical Outlook: Technically, SGMT is showing sideways momentum. Immediate support is located at $5.68, while resistance sits at $9.37. Short-term momentum is weak, with the stock down 5.2% recently.
Market Sentiment: SGMT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $25.60 (+236.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SGMT is showing sideways momentum. Immediate support is located at $5.68, while resistance sits at $9.37. Short-term momentum is weak, with the stock down 5.2% recently.
Market Sentiment: SGMT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $25.60 (+236.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$4.77 -
$7.11
Company Quality Score
56/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
47.4%
All Signals
- BEARISH: Price extended above range (+7.0% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BEARISH: Downward momentum (-5.2%)
- BULLISH: Trading 236.4% below Wall St target ($25.60)
Trading Range Analysis
30-Day Trading Range
$4.77 -
$7.11
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$5.68
Resistance Level
$9.37
Current Trend
Sideways
Technical data as of
May 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.16
Wall Street Target
$25.60
(+236.4%)
Share & Embed Analysis
Last updated: May 02, 2026 10:42 PM ET
Data refreshes hourly during market hours. Next update: 11:42 PM
Data refreshes hourly during market hours. Next update: 11:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SGMT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
David Happel
SELL
12101 shares
2026-02-10
Thierry Chauche
SELL
1312 shares
2026-02-10
George Kemble
SELL
37688 shares
2025-11-20
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 63 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 54 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$27 | 53 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$131 | 49 HOLD |
